Index of reports
> Cases with Febrile Neutropenia (123)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 123 Next >>
Possible Paclitaxel side effects in 54 year old female
Reported by a physician from United States on 2012-08-21
Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Carboplatin
Dosage: 6 df, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Paclitaxel
Dosage: 80 mg/m2, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Pegfilgrastim
Dosage: 480 mug, unk
Indication: Chemotherapy
Start date: 2011-12-22
Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine
Possible Paclitaxel side effects in 23 year old female
Reported by a physician from United States on 2012-08-14
Patient: 23 year old female, weighing 43.7 kg (96.1 pounds)
Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 582 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Carboplatin
Dosage: 305 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Crizotinib
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-26
End date: 2011-12-29
Paclitaxel
Dosage: 195 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Paclitaxel
Dosage: 280 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Other drugs received by patient: Dexamethasone; Zofran; Lovenox; Bevacizumab; Xanax; Amitriptyline; Keppra; Bevacizumab; Ranitidine; Prochlorperazine; Lortab
Possible Paclitaxel side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10
Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 98 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2010-01-12
Paclitaxel
Dosage: 343 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2010-01-12
Other drugs received by patient: Prednisone TAB; Symbicort; Spiriva
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09
Patient: female
Reactions: Vomiting, Febrile Neutropenia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cisplatin
Dosage: on day 1
Indication: Endometrial Cancer
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Endometrial Cancer
Paclitaxel
Dosage: on day 2
Indication: Endometrial Cancer
Other drugs received by patient: Growth Hormone
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-08-03
Patient: female, weighing 43.7 kg (96.1 pounds)
Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 305 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Carboplatin
Dosage: 582 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Crizotinib
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-26
End date: 2011-12-29
Paclitaxel
Dosage: 280 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Paclitaxel
Dosage: 195 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Other drugs received by patient: Bevacizumab; Dexamethasone; Zofran; Keppra; Bevacizumab; Prochlorperazine; Lovenox; Xanax; Amitriptyline; Ranitidine; Lortab
Possible Paclitaxel side effects in female
Reported by a physician from Ireland on 2012-08-02
Patient: female, weighing 94.9 kg (208.8 pounds)
Reactions: Febrile Neutropenia, Catheter Site Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2010-12-21
End date: 2011-01-05
Afinitor
Dosage: 10 mg daily
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-11-30
End date: 2010-12-11
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-01-27
Comparator Trastuzumab
Dosage: 380 mg, unk
Indication: Breast Cancer Metastatic
Start date: 2010-11-30
Comparator Trastuzumab
Dosage: no treatment received
Start date: 2010-12-15
End date: 2010-12-20
Comparator Trastuzumab
Dosage: unk
Start date: 2010-12-21
Comparator Trastuzumab
Dosage: 190 mg, unk
End date: 2010-12-07
Paclitaxel
Dosage: no treatment received
Start date: 2010-12-15
End date: 2010-12-19
Paclitaxel
Dosage: 60 mg, unk
Start date: 2010-12-20
Paclitaxel
Dosage: 80 mg/m2 day 1,8,5 of 28 day cycle
Indication: Breast Cancer Metastatic
End date: 2010-12-14
Other drugs received by patient: Naproxen; Amitriptline Hydrochloride TAB; Crestor; Atecor; Fluconazole
Possible Paclitaxel side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-30
Patient: male, weighing 83.3 kg (183.3 pounds)
Reactions: Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-07-12
Paclitaxel
Start date: 2012-07-12
Possible Paclitaxel side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Paclitaxel side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Paclitaxel side effects in 73 year old male
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient: 73 year old male, weighing 48.0 kg (105.6 pounds)
Reactions: Febrile Neutropenia, Pulmonary Embolism, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Paclitaxel
Other drugs received by patient: Furosemide; Lansoprazole; Gasmotin; Maglax
Possible Paclitaxel side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Paclitaxel side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-19
Patient: 42 year old female
Reactions: Febrile Neutropenia, Suicidal Ideation, Dysphemia, Anxiety, Hallucinations, Mixed, Transient Psychosis, Disturbance in Attention, Somatoform Disorder, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bisulepin
Dosage: 2 mg
Indication: Premedication
Dexamethasone
Dosage: 12 mg
Indication: Premedication
Ondansetron
Dosage: 8 mg
Indication: Premedication
Paclitaxel
Dosage: 80 mg/m2, per week
Indication: Breast Cancer
Ranitidine
Dosage: 150 mg
Indication: Premedication
Other drugs received by patient: Cyclophosphamide; Doxorubicin HCL
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Dosage: on days 1 and 8 every 21 days
Indication: Breast Cancer
Herceptin
Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed
Herceptin
Dosage: over 90 min on day 1
Indication: Breast Cancer
Herceptin
Dosage: over 30 min weekly
Paclitaxel
Dosage: over 1 h on days 1 and 8 every 21 days
Indication: Breast Cancer
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Indication: Breast Cancer
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Paclitaxel
Indication: Breast Cancer
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female, weighing 43.7 kg (96.1 pounds)
Reactions: Nephrolithiasis, Febrile Neutropenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 582 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Carboplatin
Dosage: 305 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Crizotinib
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-27
End date: 2011-12-29
Paclitaxel
Dosage: 280 mg, cyclic, every 3 weeks
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-30
End date: 2011-12-30
Paclitaxel
Dosage: 195 mg, once
Start date: 2012-01-25
End date: 2012-01-25
Other drugs received by patient: Bevacizumab; Lovenox; Bevacizumab; Lortab; Prochlorperazine; Dexamethasone; Xanax; Amitriptyline; Zofran; Keppra; Ranitidine
Possible Paclitaxel side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 70 year old male, weighing 64.8 kg (142.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 465 mg once iv
Start date: 2012-01-30
End date: 2012-01-30
Paclitaxel
Dosage: 372 mg once iv
Indication: Oesophageal Squamous Cell Carcinoma
Start date: 2012-01-30
End date: 2012-01-30
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-11
Patient: female, weighing 48.5 kg (106.7 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk mg, qd
Indication: Gastric Cancer
Start date: 2012-05-31
End date: 2012-06-21
Everolimus
Dosage: 5 mg, qd
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-05-31
End date: 2012-07-05
Paclitaxel
Dosage: 175 mg/m2, qw3
Indication: Gastric Cancer
Start date: 2012-05-31
End date: 2012-06-21
Possible Paclitaxel side effects in 74 year old female
Reported by a physician from Japan on 2012-06-29
Patient: 74 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Blood Bilirubin Increased, General Physical Condition Abnormal, Urinary Tract Infection, Nail Avulsion, Febrile Neutropenia, Pancytopenia, Pyrexia, Rash, Haematemesis, Hepatic Encephalopathy, Oedema Peripheral, Duodenal Ulcer Haemorrhage, Stevens-Johnson Syndrome, Cardiac Failure Congestive, Hepatitis Fulminant
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Paclitaxel
Start date: 2010-04-27
End date: 2010-04-27
Paclitaxel
Start date: 2010-05-04
End date: 2010-05-04
Paclitaxel
Indication: Breast Cancer Stage II
Start date: 2010-04-20
End date: 2010-04-20
Taxotere
Dosage: three [**] one [yasu]; cycles 1-11
Indication: Breast Cancer Stage II
Start date: 2010-06-10
End date: 2010-09-08
Trastuzumab
Dosage: dosage unknown and three [**] one [yasu]
Indication: Breast Cancer Stage II
Start date: 2010-04-20
End date: 2010-05-11
Trastuzumab
Start date: 2010-05-27
Other drugs received by patient: Zantac; Allegra; Allegra; Candesartan Cilexetil
Possible Paclitaxel side effects in 48 year old female
Reported by a physician from United States on 2012-06-28
Patient: 48 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: unk
Indication: Breast Cancer
Start date: 2010-02-09
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2010-02-09
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2010-02-09
Paclitaxel
Dosage: 80 mg/m2, unk
Indication: Breast Cancer
Start date: 2010-02-09
Pegfilgrastim
Dosage: 5 mug/kg, unk
Indication: Breast Cancer
Start date: 2010-02-09
Possible Paclitaxel side effects in 54 year old female
Reported by a physician from United States on 2012-06-26
Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Pancytopenia, Febrile Neutropenia, Device Related Infection, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Carboplatin
Dosage: 6 df, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Paclitaxel
Dosage: 80 mg/m2, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Pegfilgrastim
Dosage: 480 mug, unk
Indication: Chemotherapy
Start date: 2011-12-22
Other drugs received by patient: Aloxi; Compazine; Decadron; Emend; Zofran; Tylenol (Caplet); Levaquin
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-06-18
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-03-21
Doxorubicin HCL
Dosage: 20mgm2 weekly
Indication: Breast Cancer
Start date: 2012-03-21
Lapatinib
Dosage: 500mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-21
Paclitaxel
Dosage: 80mgm2 weekly
Indication: Breast Cancer
Start date: 2012-03-21
Trastuzumab
Dosage: 8mgk every 3 weeks
Indication: Breast Cancer
Start date: 2012-03-21
Possible Paclitaxel side effects in 37 year old female
Reported by a physician from United States on 2012-06-07
Patient: 37 year old female, weighing 56.8 kg (125.0 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Febrile Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 15 mg/kg, q3wk
Indication: Breast Cancer
Start date: 2008-09-30
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2008-09-30
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2008-09-30
Paclitaxel
Dosage: 80 mg/m2, unk
Indication: Breast Cancer
Start date: 2008-09-30
Paclitaxel
Dosage: 6 mg, unk
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Breast Cancer
Start date: 2008-09-30
Possible Paclitaxel side effects in 54 year old female
Reported by a physician from United States on 2012-06-05
Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: White Blood Cell Count Decreased, Chills, Anaemia, Febrile Neutropenia, Headache, Hypokalaemia, Hypomagnesaemia, Platelet Count Decreased, Neutrophil Count Decreased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Carboplatin
Dosage: 6 df, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Cyclosporine
Dosage: 1056 mg, unk
Indication: Breast Cancer
Start date: 2011-11-10
Doxorubicin HCL
Dosage: 105 mg, unk
Indication: Breast Cancer
Start date: 2011-11-10
Paclitaxel
Dosage: 80 mg/m2, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Pegfilgrastim
Dosage: 480 mug, unk
Indication: Chemotherapy
Start date: 2011-12-22
Other drugs received by patient: Levaquin; Aloxi; Tylenol (Caplet); Compazine; Decadron; Emend; Zofran
Possible Paclitaxel side effects in male
Reported by a physician from Germany on 2012-06-04
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Stomatitis, Febrile Neutropenia, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Avastin
Dosage: reduced to 70%
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-09
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-09
Possible Paclitaxel side effects in 40 year old female
Reported by a individual with unspecified qualification from United States on 2012-05-31
Patient: 40 year old female, weighing 63.3 kg (139.3 pounds)
Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, Neutrophil Count Decreased, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: total dose 914 mg, last administered date 09 november 2011
Indication: Cervix Carcinoma
Start date: 2011-07-28
Paclitaxel
Dosage: total dose 285 mg, last administered date 09 november 2011
Indication: Cervix Carcinoma
Start date: 2011-07-28
Topotecan Hydrochloride
Dosage: total dose 3.6 mg, last administered date 11 november 2011
Indication: Cervix Carcinoma
Start date: 2011-07-28
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-30
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Indication: Breast Cancer
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Paclitaxel
Indication: Breast Cancer
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: female
Reactions: Thrombosis, Agitation, Headache, Peripheral Sensory Neuropathy, Malaise, Granulocytopenia, Stomatitis, Hyperglycaemia, Anaemia, Intestinal Obstruction, Neutropenia, Bone Pain, Pain, Gastrointestinal Inflammation, Constipation, Hypokalaemia, Fatigue, Depression, Thrombocytopenia, Decreased Appetite, Lethargy, Pharyngitis, Vomiting, Dyspnoea, Nausea, Lymphopenia, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Anxiety, Syncope, Embolism, Diarrhoea, Leukopenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Cyclophosphamide
Indication: Breast Cancer
Doxorubicin HCL
Dosage: 60 mg/m2 for standard arm and 24 mg/m2 for continuous arm
Indication: Breast Cancer
Granulocyte Colony Stimulating Factor
Indication: Palliative Care
Paclitaxel
Indication: Breast Cancer
Possible Paclitaxel side effects in 67 year old male
Reported by a physician from Greece on 2012-05-28
Patient: 67 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Diarrhoea, Chills, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-15
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-15
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-15
Possible Paclitaxel side effects in
Reported by a individual with unspecified qualification from United States on 2012-05-28
Patient:
Reactions: Pain, Mental Status Changes, Pulmonary Embolism, Constipation, Neuropathy Peripheral, Fatigue, Dyspepsia, Oral Candidiasis, Oedema, Decreased Appetite, Hypovolaemia, Blood Alkaline Phosphatase Increased, Vomiting, Dysphagia, Nausea, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Brachial Plexopathy, Anxiety, Mucosal Inflammation, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Neutropenia
Drug(s) suspected as cause:
Paclitaxel
Dosage: on days 1-8
Indication: Breast Cancer Metastatic
Xeloda
Dosage: on days 1-15
Administration route: Oral
Indication: Breast Cancer Metastatic
Possible Paclitaxel side effects in 33 year old female
Reported by a physician from United States on 2012-05-27
Patient: 33 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, unk
Indication: Breast Cancer
Start date: 2011-11-08
Carboplatin
Dosage: unk
Indication: Breast Cancer
Start date: 2011-11-08
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-08
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-08
Paclitaxel
Dosage: 80 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-08
Pegfilgrastim
Dosage: 24 mg, unk
Indication: Chemotherapy
Start date: 2012-03-21
Other drugs received by patient: Prochlorperazine; Ondansetron; Ibuprofen; Imodium
Page 1 Next >>
|